Peregrine Pharmaceuticals Inc (NASDAQ:PPHM)

Friday’s trading has closed, but PPHM is being traded in the after-hours session. After-Hours quote »
1.63
Delayed Data
As of 4:00pm ET
 +0.06 / +3.82%
Today’s Change
1.19
Today|||52-Week Range
3.18
+17.27%
Year-to-Date

Today’s Trading

Previous close1.57
Today’s open1.60
Day’s range1.57 - 1.66
Volume3,136,545
Average volume (3 months)1,148,073
Market cap$285.9M
Dividend yield--
Data as of 4:00pm ET, 03/06/2015

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-42.42%
Earnings growth (next 5 years)--
Revenue growth (last year)+3.31%
P/E ratioNM
Price/Sales10.03
Price/Book4.15

Competitors

 Today’s
change
Today’s
% change
SNTASynta Pharmaceutical...-0.14-5.24%
AMBIAmbit Biosciences Co...----
STMLStemline Therapeutic...-0.15-0.94%
SVASinovac Biotech Ltd-0.03-0.60%
Data as of 4:00pm ET, 03/06/2015

Financials

Last reporting dateMarch 6, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$22.4M
Annual profit (last year)-$35.4M
Net profit margin-157.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Steven W. King
CFO &
Principal Accounting Officer
Paul J. Lytle
Corporate headquarters
Tustin, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account